Results 101 to 110 of about 6,137 (264)

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

open access: yesMolecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu   +10 more
wiley   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

open access: yesMolecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena   +15 more
wiley   +1 more source

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma‐cfDNA of advanced breast cancer patients: A feasibility proof‐of‐concept study

open access: yesMolecular Oncology, EarlyView.
Circulating tumor cells (CTCs) and plasma cell‐free DNA (cfDNA) were analyzed to detect ESR1 mutations and methylation in patients with advanced breast cancer. CTC‐derived DNA showed higher sensitivity for mutation detection and revealed complementary genetic and epigenetic alterations, highlighting the added value of CTC analysis for understanding ...
Dimitra Stergiopoulou   +12 more
wiley   +1 more source

A certificateless aggregate signature scheme for security and privacy protection in VANET

open access: yes, 2023
[[abstract]]In the vehicular ad hoc network, moving vehicles can keep communicating with each other by entering or leaving the network at any time to establish a new connection.
Ca, Eko Fajar;Cahyadi, Eko Fajar;Su, Tzu-Wei;Su, Tzu-Wei;Ya, Chou-Chen;Yang, Chou-Chen;黃明祥;Hwang, Min-Shiang
core  

Interpreting the effects of DNA polymerase variants at the structural level

open access: yesMolecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi   +7 more
wiley   +1 more source

Id-Based Aggregate Signature Scheme and Its Application in Authenticated Routing

open access: yes, 2014
An aggregate signature scheme can aggregate n signatures on n distinct messages from n distinct signers into a single signature.Thus,n verification equations can be reduced to one.So the aggregate signature adapts to Mobile Ad hoc Network (MANET).
Teng, Jikai, Wang, Daxing
core  

Cryptanalysis of a Compact Certificateless Aggregate Signature Scheme

open access: yes, 2020
In this paper, we cryptanalyze a recently proposed compact certificateless aggregate signature scheme (CCLAS) and show that it is in fact insecure against a Type-I attack.
Gwoboa Horng   +2 more
core  

A Secure Data Transmission Using Efficient Aggregate Signature Scheme to Verify Data in Wireless Sensor N/W [PDF]

open access: yes, 2018
We stretch an ID-based aggregate signature (IBAS) scheme for WSNs in cluster-based method . The opponent in our refuge model has the competence to presentation any alliance attacks. If an opponent can use some solitary signatures counting invalid ones to
Dinesh Kumar, Ganti   +2 more
core  

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Home - About - Disclaimer - Privacy